Elevated KIAA0101 expression is a marker of recurrence in human gastric cancer

被引:43
作者
Zhu, Kun [1 ]
Diao, Dongmei [1 ]
Dang, Chengxue [1 ]
Shi, Lei [1 ]
Wang, Jianguang [2 ]
Yan, Rong [1 ]
Yuan, Dawei [1 ]
Li, Kang [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Surg Oncol, Xian 710049, Peoples R China
[2] Henan Sci & Technol Univ, Affiliate Hosp, Luoyang, Peoples R China
关键词
PCNA-ASSOCIATED FACTOR; CELL NUCLEAR ANTIGEN; HEPATOCELLULAR-CARCINOMA; DNA-REPLICATION; POOR-PROGNOSIS; LUNG-CANCER; GENE; P15(PAF); PROTEIN; OVEREXPRESSION;
D O I
10.1111/cas.12083
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastric cancer (GC) is one of the most common malignant tumors with a high rate of recurrence, which results in surgery being unsuccessful. Therefore, it is important to find the reason for the surgery failing. The purpose of the present study was to investigate a factor related to recurrence. Expression of KIAA0101 was assessed in 61 paired human primary GC and non-cancerous gastric tissue using immunohistochemistry. After surgery, all 61 patients were followed regularly for more than 24months or until death to analyze the 2-year survival rate and recurrence. After suppressing KIAA0101 by RNA interference in human GC cell lines, the cell viability was detected using MTT. We are first to find that KIAA0101 was elevated in GC tissues compared with paired non-cancerous gastric tissues. Immunohistochemical staining also revealed the predominant nuclear localization of KIAA0101 protein. Despite these findings, GC patients with elevated KIAA0101 expression levels exhibited a high recurrence and subsequently poor prognosis in the survival study. Also, cell viability was significantly inhibited after suppressing KIAA0101 in GC cells, suggesting that KIAA0101 might promote cancer cell proliferation. KIAA0101 is increased in human GC and is a marker of recurrence.
引用
收藏
页码:353 / 359
页数:7
相关论文
共 27 条
[1]   CYCLIN PCNA IS THE AUXILIARY PROTEIN OF DNA POLYMERASE-DELTA [J].
BRAVO, R ;
FRANK, R ;
BLUNDELL, PA ;
MACDONALDBRAVO, H .
NATURE, 1987, 326 (6112) :515-517
[2]   Epidemiology of upper gastrointestinal malignancies [J].
Crew, KD ;
Neugut, AI .
SEMINARS IN ONCOLOGY, 2004, 31 (04) :450-464
[3]   Epigenetics in human disease and prospects for epigenetic therapy [J].
Egger, G ;
Liang, GN ;
Aparicio, A ;
Jones, PA .
NATURE, 2004, 429 (6990) :457-463
[4]   Proliferating cell nuclear antigen (PCNA)-associated KIAA0101/PAF15 protein is a cell cycle-regulated anaphase-promoting complex/cyclosome substrate [J].
Emanuele, Michael J. ;
Ciccia, Alberto ;
Elia, Andrew E. H. ;
Elledge, Stephen J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (24) :9845-9850
[5]   KIAA0101 (OEACT-1), an expressionally down-regulated and growth-inhibitory gene in human hepatocellular carcinoma [J].
Guo, Minglei ;
Li, Jinjun ;
Wan, Dafang ;
Gu, Jianren .
BMC CANCER, 2006, 6 (1)
[6]   Oncogenic role of KIAA0101 interacting with proliferating cell nuclear antigen in pancreatic cancer [J].
Hosokawa, Masayo ;
Takehara, Akio ;
Matsuda, Koichi ;
Eguchi, Hidetoshi ;
Ohigashi, Hiroaki ;
Ishikawa, Osamu ;
Shinomura, Yasuhisa ;
Imai, Kohzoh ;
Nakamura, Yusuke ;
Nakagawa, Hidewaki .
CANCER RESEARCH, 2007, 67 (06) :2568-2576
[7]   KIAA0101 Is Overexpressed, and Promotes Growth and Invasion in Adrenal Cancer [J].
Jain, Meenu ;
Zhang, Lisa ;
Patterson, Erin E. ;
Kebebew, Electron .
PLOS ONE, 2011, 6 (11)
[8]  
Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI [10.3322/caac.20006, 10.3322/caac.21387]
[9]   KIAA0101 Interacts with BRCA1 and Regulates Centrosome Number [J].
Kais, Zeina ;
Barsky, Sanford H. ;
Mathsyaraja, Haritha ;
Zha, Alicia ;
Ransburgh, Derek J. R. ;
He, Gang ;
Pilarski, Robert T. ;
Shapiro, Charles L. ;
Huang, Kun ;
Parvin, Jeffrey D. .
MOLECULAR CANCER RESEARCH, 2011, 9 (08) :1091-1099
[10]   Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world [J].
Kamangar, Farin ;
Dores, Graca M. ;
Anderson, William F. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (14) :2137-2150